In the ever-evolving landscape of polymer technology, Teknor Apex stands as a beacon of innovation. Celebrating its centennial year in 2024, the company has consistently pushed the boundaries of polymer science, delivering cutting-edge solutions for the healthcare and medical device industries. Through decades of collaboration with partners and customers, Teknor Apex has cultivated a reputation for excellence and reliability.
The company’s dedication to advancing healthcare is exemplified by its comprehensive range of polymer solutions tailored to meet stringent industry standards. By harnessing expertise in multiple polymer technologies such as PVC, TPEs, and engineered thermoplastics, Teknor Apex offers materials that cater to a wide array of healthcare applications. The flagship product lines—Apex, Flexalloy, and Medalist—are renowned for their superior performance and innovative properties, addressing both general and specialized needs within the healthcare sector.
A significant milestone in Teknor Apex’s commitment to innovation is the introduction of the Medalist MD-90000 Series at COMPAMED 2024. This groundbreaking series addresses a critical challenge in biopharmaceutical tubing: achieving exceptional clarity while minimizing spallation. Traditionally, materials offering low spallation are opaque, forcing designers to compromise on clarity. However, through collaborative efforts with key suppliers, Teknor Apex’s R&D team developed two new grades, MD-91760 and MD-91970, which set a new standard for TPE tubing materials. These compounds not only provide unmatched spallation performance but also maintain transparency and offer improved recyclability, setting them apart from other materials in the market.
Teknor Apex’s success is underpinned by its collaborative approach to innovation. Working closely with suppliers and customers, the company integrates the latest advancements in polymer technology into its products. State-of-the-art Application Development Centers facilitate real-world testing and optimization, accelerating time-to-market for new innovations. Moreover, Teknor Apex’s unwavering commitment to quality ensures that all materials undergo rigorous evaluation to meet the highest standards of performance and reliability.
As the healthcare industry navigates complex regulatory requirements, Teknor Apex remains proactive in developing formulations that comply with evolving standards. The company has been instrumental in transitioning its product portfolio to non-DEHP alternatives, addressing potential health risks associated with certain chemicals. By staying ahead of regulatory changes, Teknor Apex helps its customers avoid compliance issues and costly recalls.
Moving forward, Teknor Apex will continue to drive innovation and deliver superior polymer solutions that shape the future of healthcare. Through its deep expertise, collaborative spirit, and relentless focus on quality, the company is poised to make lasting contributions to the advancement of medical devices and biopharmaceuticals, ensuring a healthier and more sustainable future for all.